News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Sujit S. Sansgiry, PhD

Articles by Sujit S. Sansgiry, PhD

Correspondence regarding, "Cost Effectiveness of Thromboprophylaxis With a Low-Molecular-Weight Heparin Versus Unfractionated Heparin in Acutely Ill Medical Inpatients"

ByAlexander C. Okwonna, PharmD,Sujit S. Sansgiry, PhD

March 1st 2005

Latest Updated Articles

$Correspondence regarding, "Cost Effectiveness of Thromboprophylaxis With a Low-Molecular-Weight Heparin Versus Unfractionated Heparin in Acutely Ill Medical Inpatients"$
Correspondence regarding, "Cost Effectiveness of Thromboprophylaxis With a Low-Molecular-Weight Heparin Versus Unfractionated Heparin in Acutely Ill Medical Inpatients"
Published: March 1st 2005 | Updated:

Trending on AJMC

FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis

New Partnership Model Boosts Maternal Outcomes in Medicaid ACOs

Better Food, Better Health: Redefining Chronic Disease Care Through Nutrition

Value-Based Care Interventions and Management of CKD Progression

CAR T-Cell Therapy Holds Potential in SCLC, but Significant Barriers Remain

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

© 2025 MJH Life Sciences^®

All rights reserved.